{"text": "congressional inquiry into alzheimer drug faults maker fda nyt biib"}
{"text": "breaking gt rife with irregularities congressional investigation reveals fdas approval of aduhelm marked by secret discussions breaches of protocol via biib"}
{"text": "an aduhelm article is breaking news what year is it biib"}
{"text": "breaking part 2 gt seeking maximum profits biogen biib set an unjustifiably high price for alzheimers treatment investigation finds via and me"}
{"text": "congressional investigaiton into biib aduhelm seems quite damning and extensively cites stat s coverage top work"}
{"text": "biogen stands by integrity of actions we have taken biib"}
